423 related articles for article (PubMed ID: 21839575)
21. Comparison of risk factors for placental abruption and placenta previa: case-cohort study.
Matsuda Y; Hayashi K; Shiozaki A; Kawamichi Y; Satoh S; Saito S
J Obstet Gynaecol Res; 2011 Jun; 37(6):538-46. PubMed ID: 21375675
[TBL] [Abstract][Full Text] [Related]
22. Comparison of maternal risk factors between placental abruption and placenta previa.
Yang Q; Wen SW; Phillips K; Oppenheimer L; Black D; Walker MC
Am J Perinatol; 2009 Apr; 26(4):279-86. PubMed ID: 19021090
[TBL] [Abstract][Full Text] [Related]
23. Association between in vitro fertilization and ischemic placental disease by gestational age.
Johnson KM; Hacker MR; Thornton K; Young BC; Modest AM
Fertil Steril; 2020 Sep; 114(3):579-586. PubMed ID: 32709377
[TBL] [Abstract][Full Text] [Related]
24. The comparison of placental abruption coupled with and without preeclampsia and/or intrauterine growth restriction in singleton pregnancies.
Ni S; Wang X; Cheng X
J Matern Fetal Neonatal Med; 2021 May; 34(9):1395-1400. PubMed ID: 31248311
[TBL] [Abstract][Full Text] [Related]
25. Long-term maternal morbidity and mortality associated with ischemic placental disease.
Adams T; Yeh C; Bennett-Kunzier N; Kinzler WL
Semin Perinatol; 2014 Apr; 38(3):146-50. PubMed ID: 24836826
[TBL] [Abstract][Full Text] [Related]
26. Evidence of placental abruption as a chronic process: associations with vaginal bleeding early in pregnancy and placental lesions.
Ananth CV; Oyelese Y; Prasad V; Getahun D; Smulian JC
Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):15-21. PubMed ID: 16513243
[TBL] [Abstract][Full Text] [Related]
27. Placental abruption and placental weight - implications for fetal growth.
Ananth CV; Williams MA
Acta Obstet Gynecol Scand; 2013 Oct; 92(10):1143-50. PubMed ID: 23750805
[TBL] [Abstract][Full Text] [Related]
28. [Analysis of risk factors for uteroplacental apoplexy complicating placental abruption].
Cheng WW; Lin SQ
Zhonghua Fu Chan Ke Za Zhi; 2008 Aug; 43(8):593-6. PubMed ID: 19087494
[TBL] [Abstract][Full Text] [Related]
29. Risk of ischemic placental disease is increased following in vitro fertilization with oocyte donation: a retrospective cohort study.
Modest AM; Johnson KM; Karumanchi SA; Resetkova N; Young BC; Fox MP; Wise LA; Hacker MR
J Assist Reprod Genet; 2019 Sep; 36(9):1917-1926. PubMed ID: 31359234
[TBL] [Abstract][Full Text] [Related]
30. Association of caesarean delivery for first birth with placenta praevia and placental abruption in second pregnancy.
Yang Q; Wen SW; Oppenheimer L; Chen XK; Black D; Gao J; Walker MC
BJOG; 2007 May; 114(5):609-13. PubMed ID: 17355267
[TBL] [Abstract][Full Text] [Related]
31. A comparison between the pregnancy outcome in women both with or without threatened abortion.
Dadkhah F; Kashanian M; Eliasi G
Early Hum Dev; 2010 Mar; 86(3):193-6. PubMed ID: 20231080
[TBL] [Abstract][Full Text] [Related]
32. Distinguishing pathological from constitutional small for gestational age births in population-based studies.
Ananth CV; Vintzileos AM
Early Hum Dev; 2009 Oct; 85(10):653-8. PubMed ID: 19786331
[TBL] [Abstract][Full Text] [Related]
33. Defective Placentation Syndromes and Intellectual Disability in the Offspring: Nationwide Cohort and Sibling-Controlled Studies.
Villamor E; Susser ES; Cnattingius S
Am J Epidemiol; 2022 Aug; 191(9):1557-1567. PubMed ID: 35380610
[TBL] [Abstract][Full Text] [Related]
34. [Mode of conception, acompanying medical disorders and complications in the second half of pregnancy in women over the age of 35].
Dakov T; Dimitrova V; Maseva A; Todorov T
Akush Ginekol (Sofiia); 2014; 53(8):4-11. PubMed ID: 25672082
[TBL] [Abstract][Full Text] [Related]
35. Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation.
Wadhwa PD; Garite TJ; Porto M; Glynn L; Chicz-DeMet A; Dunkel-Schetter C; Sandman CA
Am J Obstet Gynecol; 2004 Oct; 191(4):1063-9. PubMed ID: 15507922
[TBL] [Abstract][Full Text] [Related]
36. [Epidemiology of vascular placental disease].
Lejeune V
Ann Med Interne (Paris); 2003; 154(5-6):310-5. PubMed ID: 15027584
[TBL] [Abstract][Full Text] [Related]
37. Risk factors for intrauterine growth restriction in a socio-economically disadvantaged region.
Kleijer ME; Dekker GA; Heard AR
J Matern Fetal Neonatal Med; 2005 Jul; 18(1):23-30. PubMed ID: 16105788
[TBL] [Abstract][Full Text] [Related]
38. Ischemic placental disease and risks of perinatal mortality and morbidity and neurodevelopmental outcomes.
Ananth CV; Friedman AM
Semin Perinatol; 2014 Apr; 38(3):151-8. PubMed ID: 24836827
[TBL] [Abstract][Full Text] [Related]
39. Previous preeclampsia and risks of adverse outcomes in subsequent nonpreeclamptic pregnancies.
Wikström AK; Stephansson O; Cnattingius S
Am J Obstet Gynecol; 2011 Feb; 204(2):148.e1-6. PubMed ID: 21055722
[TBL] [Abstract][Full Text] [Related]
40. Birth characteristics and subsequent risks of maternal cardiovascular disease: effects of gestational age and fetal growth.
Bonamy AK; Parikh NI; Cnattingius S; Ludvigsson JF; Ingelsson E
Circulation; 2011 Dec; 124(25):2839-46. PubMed ID: 22124377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
